NeisVac C: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Pfizer Inc.
Country: Canada
Condition: Meningococcal Meningitis Prophylaxis
Class: Immunologic agents, Vaccine combinations
Form: Liquid solution, Intramuscular (IM)
Ingredients: Neisseria meningitidis group C polysaccharide conjugated with (joined to) 10 to 20 micrograms of tetanus toxoid protein, adsorbed on 0.5 mg aluminium hydroxide